Here is how they compare:
Revenue: $16.7 million
Operating loss: $1.1 million
Year-over-year revenue dip: $3.9 million
Sales: $307.7 million
Operating loss: $1 million
Year-over-year sales increase: $17 million
Surgalign & NuVasive: How they line up in Q1
Medical technology companies Surgalign and NuVasive posted their first quarter financial results for 2023.
From repetitive to real-time: AI that lightens the back-office load
Recommended Live Webinar on Jan 22, 2026 12:00 PM - 1:00 PM CST